CD8A and neoplasm: CD8α, produced from CD8A, is a canonical marker for the T cell population involved in tumour surveillance and forms a heterodimer with CD8β, or may homodimerise [63]; CD8A is the only gene exclusive to T-net that correlates with nivolumab response in MEL_PROG.